89607-15-8

Basic information

• Product Name: 1H-Pyrazole, 3-bromo-1-methyl-4-nitro-
• CAS NO: 89607-15-8
• Molecular Formula: C4H4BrN3O2
• Molecular Weight: 205.999
• Mol File: 89607-15-8.mol

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole, 3-bromo-1-methyl-4-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole, 3-bromo-1-methyl-4-nitro-(89607-15-8)
• EPA Substance Registry System: 1H-Pyrazole, 3-bromo-1-methyl-4-nitro-(89607-15-8)

Safety Data

• Hazardous Substances Data: 89607-15-8(Hazardous Substances Data)

Usage

Compound type

1H-Pyrazole derivative

Substitution positions

3-bromo, 1-methyl, 4-nitro

Usage

Organic synthesis, pharmaceutical research

Potential pharmacological activities

Antibacterial, antifungal, treatment of various diseases and conditions

Utility

Building block in the synthesis of biologically active compounds

Upstream product

• 784193-37-9 3-bromo-4‐nitro‐1H‐pyrazole 
• 74-88-4 methyl iodide 
• 20055-00-9 1-methyl-4-nitro-1H-pyrazol-3-ylamine 
• 77-78-1 dimethyl sulfate 

Relevant articles and documents

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

PYRROLOTRIAZINE INHIBITORS OF IRAK4 ACTIVITY

The present invention relates to pyrrolotriazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.

PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY

The present invention relates to pyrazolopyrimidine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.

THIENOPYRAZINE INHIBITORS OF IRAK4 ACTIVITY

The present invention relates to thienopyrazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.

PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY

The present invention relates to pyrrolopyridazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.